HOME › DRUGS › OBLIMERSEN
ACTIVE SUBSTANCE / INN

OBLIMERSEN

Brand name(s): Genasense
EMA LISTED
REFUSED
Melanoma
ACTIVE SUBSTANCE
Oblimersen
REGULATORS
EMA
SPONSORS / MAH
Genta Development Ltd. c/o Ross Craig
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
GenasenseGenta Development Ltd. c/o Ross CraigRefusedMelanoma

FULL INTELLIGENCE ON OBLIMERSEN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →